Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_assertion description "[We tested the combinations of the Akt inhibitors MK2206 or perifosine with the BRAF(V600E) inhibitor PLX4032 or the MEK1/2 inhibitor AZD6244 in thyroid cancer cells harboring both the BRAF(V600E) and PIK3CA mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_assertion evidence source_evidence_literature NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_assertion SIO_000772 22090271 NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_assertion wasDerivedFrom befree-20150227 NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_assertion wasGeneratedBy ECO_0000203 NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.
- befree-20150227 importedOn "2015-02-27" NP621683.RAXCGpR4-TC2pGt2f8_v7r35r9cpkqwCIRRSq9QEGwhps130_provenance.